Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition
JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.
Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...
Fierce Pharma8d
In buying cell therapy partner 2seventy bio for $286M, BMS takes full control of Abecma
More than a year into a strategic pivot to zero in on the multiple myeloma cell therapy Abecma, 2seventy bio is selling ...
Insider Monkey8d
11 Best Pharma Stocks to Buy According to Hedge Funds
Bristol-Myers Squibb Company’s (NYSE:BMY) recent acquisitions of oncology firms RayzeBio and Mirati and neurology firm Karuna have further ... the next 3-5 years. Johnson & Johnson (NYSE:JNJ ...
pharmaphorum9d
Neurosterix emerges with $63m for neuroscience pipeline
Another rival is Karuna Therapeutics ... which is partnered with Johnson & Johnson’s Janssen Pharma unit. Addex is also holding on to a GABAB PAM programme for substance use disorder licensed ...
MindSite News1d
Cuts to SAMHSA Would ‘Impact Americans in Every Corner of the Country’
A small federal agency that plays a big role in trying to address America's mental health crisis is in trouble.
Business Insider1d
An AI imaging firm says Johnson & Johnson stole its tech. Testimony began Monday.
In 2019, Johnson & Johnson, hoping to compete in the growing surgical robotics field, signed a multibillion-dollar contract with a small biotech company called ChemImage. Based in Pittsburgh ...
Indiatimes9d
Exclusive: Pushpa Impossible’s Karuna Pandey on the initial challenges he faced, says ‘I came to Mumbai on my own and struggled to get a break’
Karuna Pandey shares her experiences playing Pushpa, a character known for strength and resilience in the television series Pushpa Impossible. She highlights the importance of balancing personal ...
New York Post29d
Inside biohacker Bryan Johnson’s bizarre $349-a-ticket Don’t Die Summit’s supplements, penis talk and a grim reaper cameo
Bryan Johnson wants to live forever. And for just $349 per ticket and your Saturday afternoon, he promises to share the secrets of his age-defying body with us ordinary folk. The Silicon Valley ...